A detailed history of Weiss Asset Management LP transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Weiss Asset Management LP holds 7,457,060 shares of TBPH stock, worth $65.5 Million. This represents 1.94% of its overall portfolio holdings.

Number of Shares
7,457,060
Previous 7,457,060 -0.0%
Holding current value
$65.5 Million
Previous $63.2 Million 4.95%
% of portfolio
1.94%
Previous 3.74%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$8.39 - $10.22 $10.2 Million - $12.5 Million
1,219,622 Added 19.55%
7,457,060 $75.6 Million
Q2 2022

Aug 15, 2022

BUY
$8.41 - $10.34 $6.94 Million - $8.53 Million
824,951 Added 15.24%
6,237,438 $56.5 Million
Q1 2022

May 13, 2022

BUY
$8.33 - $12.96 $23.4 Million - $36.4 Million
2,810,709 Added 108.03%
5,412,487 $51.7 Million
Q4 2021

Feb 14, 2022

BUY
$7.42 - $11.05 $19.3 Million - $28.7 Million
2,601,778 New
2,601,778 $28.8 Million

Others Institutions Holding TBPH

About Theravance Biopharma, Inc.


  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $586M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Weiss Asset Management LP Portfolio

Follow Weiss Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Asset Management LP with notifications on news.